Extra-Axial Poorly Differentiated Chordoma Initially Misdiagnosed as Epithelioid Sarcoma
International Journal of Surgical Pathology · 2025-05 · 33 (3) · 646-655
DOI: 10.1177/10668969241286086 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Surgical Pathology, online erschienen am 13.11.2024. Verfasst von Paige O'Connor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Geisel School of Medicine at Dartmouth, Hanover, NH, USA. Hauptthemen laut MEDLINE: Chordoma, Sarcoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Poorly differentiated chordoma is an exceedingly rare, aggressive subtype of chordoma. These tumors typically arise in the axial skeleton of young patients, most commonly the skull base, followed by the cervical spine. Herein, we present a 60-year-old patient with longstanding knee pain and nondiagnostic imaging, initially thought to be due to osteoarthritis. No discrete mass-forming lesion was identified by radiology. Synovial histology at the time of arthroplasty revealed a multinodular proliferation of epithelioid-to-histiocytoid cells with a moderate amount of eosinophilic-to-clear, vacuolated cytoplasm. Scattered cells with high-grade nuclear atypia were present. A diagnosis of metastatic carcinoma was considered due to immunohistochemical positivity for keratin and GATA3. However, a diagnosis of epithelioid sarcoma was rendered based on clinical context, morphology, and loss of immunohistochemical expression for SMARCB1 (INI1). However, upon re-review of the tumor, brachyury was retrospectively added to the immunohistochemistry panel and showed strong positivity, thus prompting amendment of the initial diagnosis of epithelioid sarcoma to extra-axial poorly differentiated chordoma. Given the rarity of this diagnosis, molecular testing was performed which revealed a unique SMARCB1 molecular profile with a single-nucleotide variant in addition to the commonly reported loss of chromosome 22q. This report of an ultra-rare sarcoma in an uncommon anatomic site highlights multiple potential pitfalls in the diagnosis of poorly differentiated chordoma, emphasizes the importance of brachyury immunohistochemistry in rendering a correct interpretation, and underscores an opportunity for further molecular analysis to better define the molecular profile of this entity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
- Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
- Department of Radiology, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Paige O'Connor, Darcy A Kerr
Förderung
- NCI NIH HHS
Zitieren
APA
O'Connor, P., Cheung, Y. Y., Green, D. C., Lefferts, J. A., Jo, V. Y., & Kerr, D. A. (2025). Extra-Axial Poorly Differentiated Chordoma Initially Misdiagnosed as Epithelioid Sarcoma. International Journal of Surgical Pathology, 33(3), 646-655. https://doi.org/10.1177/10668969241286086
Vancouver
O'Connor P, Cheung YY, Green DC, Lefferts JA, Jo VY, Kerr DA. Extra-Axial Poorly Differentiated Chordoma Initially Misdiagnosed as Epithelioid Sarcoma. International Journal of Surgical Pathology. 2025;33(3):646-655. doi:10.1177/10668969241286086
BibTeX
@article{OConnor2025,
author = {O'Connor, Paige and Cheung, Yvonne Y and Green, Donald C and Lefferts, Joel A and Jo, Vickie Y and Kerr, Darcy A},
title = {Extra-Axial Poorly Differentiated Chordoma Initially Misdiagnosed as Epithelioid Sarcoma},
journal = {International Journal of Surgical Pathology},
year = {2025},
volume = {33},
number = {3},
pages = {646--655},
doi = {10.1177/10668969241286086}
}
EUVIMED